全文获取类型
收费全文 | 28854篇 |
免费 | 2583篇 |
国内免费 | 2026篇 |
出版年
2024年 | 54篇 |
2023年 | 256篇 |
2022年 | 687篇 |
2021年 | 1143篇 |
2020年 | 850篇 |
2019年 | 1026篇 |
2018年 | 1069篇 |
2017年 | 841篇 |
2016年 | 1140篇 |
2015年 | 1752篇 |
2014年 | 2031篇 |
2013年 | 2145篇 |
2012年 | 2592篇 |
2011年 | 2566篇 |
2010年 | 1599篇 |
2009年 | 1360篇 |
2008年 | 1791篇 |
2007年 | 1559篇 |
2006年 | 1354篇 |
2005年 | 1229篇 |
2004年 | 1178篇 |
2003年 | 986篇 |
2002年 | 857篇 |
2001年 | 486篇 |
2000年 | 396篇 |
1999年 | 363篇 |
1998年 | 241篇 |
1997年 | 168篇 |
1996年 | 141篇 |
1995年 | 126篇 |
1994年 | 135篇 |
1993年 | 86篇 |
1992年 | 141篇 |
1991年 | 128篇 |
1990年 | 100篇 |
1989年 | 94篇 |
1988年 | 72篇 |
1987年 | 52篇 |
1986年 | 55篇 |
1985年 | 61篇 |
1984年 | 35篇 |
1983年 | 43篇 |
1982年 | 41篇 |
1981年 | 39篇 |
1980年 | 43篇 |
1979年 | 38篇 |
1978年 | 34篇 |
1977年 | 31篇 |
1976年 | 31篇 |
1974年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
991.
Yarui Li Dan Guo Mudan Ren Yan Zhao Xin Wang Yifei Chen Yaping Liu Guifang Lu Shuixiang He 《Journal of cellular and molecular medicine》2019,23(9):6271-6282
Emerging evidence has indicated that deregulation of long non‐coding RNAs (lncRNAs) can contribute to the progression of human cancers, including hepatocellular carcinoma (HCC). However, the role and exact mechanism of most lncRNAs in tumours remains largely unknown. In the current study, we found a novel long non‐coding RNA termed SNAI3‐AS1 which was generally up‐regulated in HCC tissues compared with normal control. Higher expression of SNAI3‐AS1 was significantly correlated with shorter overall survival of HCC patients. Knockdown of SNAI3‐AS1 inhibited the proliferation and metastasis of HCC cells in vitro, whereas overexpression of SNAI3‐AS1 promoted the proliferation and metastasis of HCC cells. Further investigations showed that SNAI3‐AS1 could affect HCC tumorigenesis by binding up‐frameshift protein 1 (UPF1), regulating Smad7 expression and activating TGF‐β/Smad pathway. Functionally, SNAI3‐AS1 promoted HCC growth and metastasis by inducing tumour epithelial to mesenchymal transition (EMT). Taken together, these findings showed that SNAI3‐AS1 promotes the progression of HCC by regulating the UPF1 and activating TGF‐β/Smad pathway. 相似文献
992.
Leilei Yin Yingying Fang Tao Song Dan Lv Zheng Wang Li Zhu Zihui Zhao Xinhua Yin 《Journal of cellular and molecular medicine》2019,23(4):2558-2567
Diabetic cardiomyopathy (DCM) is a condition associated with significant structural changes including cardiac tissue necrosis, localized fibrosis, and cardiomyocyte hypertrophy. This study sought to assess whether and how FBXL10 can attenuate DCM using a rat streptozotocin (STZ)‐induced DCM model system. In the current study, we found that FBXL10 expression was significantly decreased in diabetic rat hearts. FBXL10 protected cells from high glucose (HG)‐induced inflammation, oxidative stress, and apoptosis in vitro. In addition, FBXL10 significantly activated PKC β2 signaling pathway in H9c2 cells and rat model. The cardiomyocyte‐specific overexpression of FBXL10 at 12 weeks after the initial STZ administration attenuated oxidative stress and inflammation, thereby reducing cardiomyocyte death and preserving cardiac function in these animals. Moreover, FBXL10 protected against DCM via activation of the PKC β2 pathway. In conclusion, FBXL has the therapeutic potential for the treatment of DCM. 相似文献
993.
Kyoungjune Pak Yun Hak Kim Sunghwan Suh Tae Sik Goh Dae Cheon Jeong Seong Jang Kim In Joo Kim Myoung‐Eun Han Sae‐Ock Oh 《Journal of cellular and molecular medicine》2019,23(4):3010-3015
As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC) increases, accurate risk stratification is required. To develop a novel prognostic scoring system for patients with PTC (n = 455), we used mRNA expression and clinical data from The Cancer Genome Atlas. We performed variable selection using Network‐Regularized high‐dimensional Cox‐regression with gene network from pathway databases. The risk score was calculated using a linear combination of regression coefficients and mRNA expressions. The risk score and clinical variables were assessed by several survival analyses. The risk score showed high discriminatory power for the prediction of event‐free survival as well as the presence of metastasis. In multivariate analysis, the risk score and presence of metastasis were significant risk factors among the clinical variables that were examined together. In the current study, we developed a risk scoring system that will help to identify suitable therapeutic options for PTC. 相似文献
994.
Yiming Liu Xiaodi Zhang Sining Zhou Jieyao Shi Yun Xu Jia He Feng Lin Anbang Wei Linfu Zhou Zhi Chen 《Journal of cellular and molecular medicine》2019,23(4):2399-2409
Golgi phosphoprotein 73 (GP73) has been regarded as a novel serum biomarker for the diagnosis of hepatocellular carcinoma (HCC) in recent years. It has been reported that the upregulation of GP73 may promote the carcinogenesis and metastasis of HCC; however, the mechanisms remain poorly understood. In this study, GP73 correlates positively with matrix metalloproteinase‐2 (MMP‐2) in HCC‐related cells and tissues. Further studies indicate that the knockdown of GP73 blocks MMP‐2 trafficking and secretion, resulting in cell invasion inhibition. Additionally, the knockdown of GP73 induces the accumulation of intracellular MMP‐2, which inhibits the phosphorylation of Src at Y416 and triggers the inhibition of SAPK/JNK and p53‐p21 signalling pathways through a negative feedback loop. Finally, the transactivation of MMP2 was inhibited by the reduction in E2F1. This study reveals that GP73 plays functional roles in the trafficking and equilibrium of epithelial‐mesenchymal transition (EMT)‐related secretory proteins and that GP73 serves as a new potential target for combating the metastasis of HCC. 相似文献
995.
996.
Jianing Tang Qiuxia Cui Dan Zhang Xing Liao Jian Zhu Gaosong Wu 《Journal of cellular and molecular medicine》2019,23(8):4980-4990
Quite a few estrogen receptor (ER)‐positive breast cancer patients receiving endocrine therapy are at risk of disease recurrence and death. ER‐related genes are involved in the progression and chemoresistance of breast cancer. In this study, we identified an ER‐related gene signature that can predict the prognosis of ER‐positive breast cancer patient receiving endocrine therapy. We collected RNA expression profiling from Gene Expression Omnibus database. An ER‐related signature was developed to separate patients into high‐risk and low‐risk groups. Patients in the low‐risk group had significantly better survival than those in the high‐risk group. ROC analysis indicated that this signature exhibited good diagnostic efficiency for the 1‐, 3‐ and 5‐year disease‐relapse events. Moreover, multivariate Cox regression analysis demonstrated that the ER‐related signature was an independent risk factor when adjusting for several clinical signatures. The prognostic value of this signature was validated in the validation sets. In addition, a nomogram was built and the calibration plots analysis indicated the good performance of this nomogram. In conclusion, combining with ER status, our results demonstrated that the ER‐related prognostic signature is a promising method for predicting the prognosis of ER‐positive breast cancer patients receiving endocrine therapy. 相似文献
997.
Xuting Bian Tianyao Liu Mei Zhou Gang He Yuanyuan Ma Youxing Shi Yunjiao Wang Hong Tang Xia Kang Mingyu Yang Jan‐ke Gustafsson Xiaotang Fan Kanglai Tang 《Journal of cellular and molecular medicine》2019,23(11):7406-7416
Achilles tendon injury is one of the challenges of sports medicine, the aetiology of which remains unknown. For a long time, estrogen receptor β (ERβ) has been known as a regulating factor of the metabolism in many connective tissues, such as bone, muscle and cartilage, but little is known about its role in tendon. Recent studies have implicated ERβ as involved in the process of tendon healing. Tendon‐derived stem cells (TDSCs) are getting more and more attention in tendon physiological and pathological process. In this study, we investigated how ERβ played a role in Achilles tendon healing. Achilles tendon injury model was established to analyse how ERβ affected on healing process in vivo. Cell proliferation assay, Western blots, qRT‐PCR and immunocytochemistry were performed to investigate the effect of ERβ on TDSCs. Here, we showed that ERβ deletion in mice resulted in inferior gross appearance, histological scores and, most importantly, increased accumulation of adipocytes during the early tendon healing which involved activation of peroxisome proliferator‐activated receptor γ (PPARγ) signalling. Furthermore, in vitro results of ours confirmed that the abnormity might be the result of abnormal TDSC adipogenic differentiation which could be partially reversed by the treatment of ERβ agonist LY3201. These data revealed a role of ERβ in Achilles tendon healing for the first time, thereby providing a new target for clinical treatment of Achilles tendon injury. 相似文献
998.
Yiming An Xia Long Ming Ma Jue Hu He Lin Dan Zhou Zheng Xing Bolong Huang Shihe Yang 《Liver Transplantation》2019,9(41)
Currently, in addition to the electroactive non‐noble metal water‐splitting electrocatalysts, a scalable synthetic route and simple activity enhancement strategy is also urgently needed. In particular, the well‐controlled synthesis of the well‐recognized metal–metal nanointer face in a single step remains a key challenge. Here, the synthesis of Cu‐supported Ni4Mo nanodots on MoOx nanosheets (Ni4Mo/MoOx) with controllable Ni4Mo particle size and d‐band structure is reported via a facile one‐step electrodeposition process. Density functional theory (DFT) calculations reveal that the active open‐shell effect from Ni‐3d‐band optimizes the electronic configuration. The Cu‐substrate enables the surface Ni–Mo alloy dots to be more electron‐rich, forming a local connected electron‐rich network, which boosts the charge transfer for effective binding of O‐related species and proton–electron charge exchange in the hydrogen evolution reaction. The Cu‐supported Ni4Mo/MoOx shows an ultralow overpotential of 16 mV at a current density of 10 mA cm?2 in 1 m KOH, demonstrating the smallest overpotential, at loadings as low as 0.27 mg cm?2, among all non‐noble metal catalysts reported to date. Moreover, an overpotential of 105 mV allows it to achieve a current density of 250 mA cm?2 in 70 °C 30% KOH, a remarkable performance for alkaline hydrogen evolution with competitive potential for applications. 相似文献
999.
Lei Qin Yu Lei Huwei Wang Jiahui Dong Yiying Wu Dengyun Zhai Feiyu Kang Ying Tao Quan‐Hong Yang 《Liver Transplantation》2019,9(29)
Metallic potassium (K) is a desirable anode for potassium secondary batteries due to its low electrode potential in nonaqueous electrolytes and high theoretical capacity. Nevertheless, instability caused by dendritic growth, large volume changes, and parasitic side reactions hamper its practical application. Here, an anode containing metallic K is fabricated by infiltrating an aligned carbon nanotube membrane (ACM) with molten K because of its good wettability to molten K due to the strong capillary forces. The K metal is spatially distributed on the 3D ACM framework, which offers sufficient electrode/electrolyte contact for charge transfer. The robust ACM host provides a large number of K nucleation sites and physically confines the K deposited there, thus mitigating dimensional changes during cycling. The pathways for electrons and ions in the anode are associated to form a mixed conducting network, which is beneficial for the electrochemical redox. Consequently, the anode shows stable plating/stripping profiles with low polarization in symmetric cells using conventional carbonate‐based electrolytes. In addition, dendrite growth is suppressed, and the anode demonstrates excellent suitability when paired with a Prussian blue cathode in a full cell. This design strategy is expected to provide a way to address the problems with using metallic K anodes. 相似文献
1000.
Chronic myeloid leukemia (CML) is a lethal malignancy, and the progress toward long‐term survival has stagnated in recent decades. Pristimerin, a quinone methide triterpenoid isolated from the Celastraceae and Hippocrateaceae families, is well‐known to exert potential anticancer activities. In this study, we investigated the effects and the mechanisms of action on CML. We found that pristimerin inhibited cell proliferation of K562 CML cells by causing G1 phase arrest. Furthermore, we demonstrated that pristimerin triggered autophagy and apoptosis. Intriguingly, pristimerin‐induced cell death was restored by an autophagy inhibitor, suggesting that autophagy is cross‐linked with pristimerin‐induced apoptosis. Further studies revealed that pristimerin could produce excessive reactive oxygen species (ROS), which then induce JNK activation. These findings provide clear evidence that pristimerin might be clinical benefit to patients with CML. 相似文献